Related Experiment Video
Updated: Sep 16, 2025

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Prenatal Exposure to Methamphetamine and Its Association With Birth Outcomes: A Meta-Analysis
Nima Rastegar-Pouyani1, Fatemeh Fakhari1, Armineh Rezagholi Lalani2
1Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
Insights
Prenatal methamphetamine exposure significantly increases the risk of preterm birth (PTB), low birth weight (LBW), and being small for gestational age (SGA). This systematic review highlights critical public health concerns regarding substance use during pregnancy.
Area of Science:
- Public Health
- Perinatal Medicine
- Toxicology
Background:
- Methamphetamine abuse is a growing global public health concern.
- Prenatal exposure to methamphetamine poses significant risks to fetal development and newborn health.
Purpose of the Study:
- To systematically review and meta-analyze the association between prenatal methamphetamine exposure and adverse birth outcomes.
- To evaluate risks for Preterm Birth (PTB), Low Birth Weight (LBW), and Small for Gestational Age (SGA).
Main Methods:
- Systematic literature search of PubMed, Web of Science, and Scopus (up to Dec 2021).
- Meta-analysis of eight observational studies using Odds Ratios (OR) and 95% Confidence Intervals (CI).
- Assessed heterogeneity, publication bias, and performed sensitivity analysis.
Main Results:
- Prenatal methamphetamine exposure is associated with a 2.64 times higher risk of PTB (OR 2.64; 95% CI 1.89-3.70).
- Associated with a 2.83 times higher risk of LBW (OR 2.83; 95% CI 1.09-7.38).
- Associated with a 1.44 times higher risk of SGA (OR 1.44; 95% CI 1.04-1.99).
Conclusions:
- A substantial association exists between prenatal methamphetamine exposure and PTB, LBW, and SGA.
- Findings underscore the critical need for interventions addressing prenatal methamphetamine use.
Purpose:
The growing prevalence of methamphetamine abuse has been regarded as a matter of great concern due to its damaging impact on public health worldwide. Our study aimed to perform a systematic review of the literature with meta-analysis to evaluate the association between prenatal methamphetamine exposure, Preterm Birth (PTB) Low Birth Weight (LBW), and being Small for Gestational Age (SGA). Later on, we investigated the association between prenatal methamphetamine use and the aforementioned birth defects.
Methods:
We conducted a systematic search of English-language articles in Web of Science, Scopus, and PubMed from inception to December 24, 2021, identifying 1223 observational studies. After removing duplicates, 911 articles remained for title and abstract screening, of which 868 were excluded. Following a full-text review of 43 studies, 35 were excluded due to insufficient data, leaving eight studies for meta-analysis. Data were analyzed using Stata 15.0, with Odds Ratio (OR) (95% Confidence Intervals (CI)) as effect sizes. Subgroup analysis was performed by sample type (urine, meconium, and …), and heterogeneity was assessed using the Chi-square test (I2 more than 50% was considered heterogenic), applying fixed- or random-effects models accordingly. Publication bias was evaluated via Egger's test and funnel plots, and sensitivity analysis was conducted to assess result robustness.
Results:
Prenatal exposure to methamphetamine was found to be associated with PTB (OR 2.64; 95% CI 1.89-3.70), LBW (OR 2.83; 95% CI 1.09-7.38), and SGA (OR 1.44; 95% CI 1.04-1.99).
Conclusion:
Our meta-analysis shows a substantial association between prenatal exposure to methamphetamine and PTB, LBW, and being SGA.
More Related Videos
Related Concept Videos
Teratogenicity
Regression Toward the Mean
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...

